Rilpivirine and pharmaceutically acceptable addition salts thereof including the hydrochloride salt of Rilpivirine

NO2024047I1Undetermined Publication Date: 2024-10-30JANSSEN PHARMA NV

View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office: NO · NO
Patent Type: Applications
Current Assignee / Owner: JANSSEN PHARMA NV
Filing Date: 2024-10-30
Publication Date: 2024-10-30

Application Information

Patent Timeline

30 Oct 2024

Application

30 Oct 2024

Publication

NO2024047I1

IPC: C07D403/12; A61K; A61K31/505; A61K31/506; A61K31/5355; A61K31/541; A61K31/551; A61K45/00; A61P31/18; C07C; C07C211/00; C07C255/42; C07C257/12; C07D; C07D233/96; C07D239/46; C07D239/47; C07D239/48; C07D401/12; C07D401/14; C07D403/14; C07D405/12; C07D407/12; C07D409/12; C07D413/12; C07D417/12

CPC: A61K31/505; A61K31/506; C07C255/42; C07C257/12; C07D239/47; C07D401/12; C07D403/12; C07D405/12

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗

Get free access to AI patent search and analysis

Check patentability, review prior art and ask IP Agent with full patent context.

Patent Text Reader

Need to check novelty before this filing date? Find Prior Art

No text content released.